Skip to main content

Clinical Trials Using Ceralasertib

Review the clinical trials studying ceralasertib on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-6 of 6

Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients with Non-Small Cell Lung Cancer
Status: Active
Location: 93 locations
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Status: Active
Location: 21 locations
Ceralasertib with or without Olaparib or Durvalumab in Treating Patients with Locally Advanced or Metastatic Solid Tumors
Status: Active
Location: 4 locations
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Status: Active
Location: 4 locations
Olaparib with Ceralasertib for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer
Status: Active
Location: University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland